Xiao Ma1, Peter Seres2, Adam Kinnaird3, Chris Fung2, Alan Wilman1,2, and Christian Beaulieu1,2
1Biomedical Engineering, University of Alberta, Edmonton, AB, Canada, 2Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, 3Urology, University of Alberta, Edmonton, AB, Canada
Synopsis
Keywords: Prostate, Aging
Motivation: T1 relaxation, T2 relaxation, mean diffusivity (MD) and volume can offer valuable information about prostate tissue remodeling that may occur with cancer and aging.
Goal(s): These age relationships are relevant for identification of cancer thresholds, but also provide insight on unique prostate zone changes with age.
Approach: 74 normal volunteers aged 19-69 years were scanned.
Results: T1, T2, MD and volume in the peripheral zone showed a positive quadratic association with age being mainly flat and then increasing after 45 years. In contrast, there were no such T1/T2/MD versus age correlations in the transition zone, despite a marked increase of volume with aging.
Impact: Quantitative T1/T2 relaxation
and mean diffusivity demonstrate microstructural
changes of the prostate, particularly in the peripheral zone and not the
transition zone, with typical aging (19-69 years) which may provide a
‘normative’ benchmark for tumor identification.
Introduction
Diffusion-weighted
imaging (DWI) with mean diffusivity (MD) mapping and T2-weighted imaging are
standard components of clinical practice for prostate MRI1. T1 and T2 mapping are not routinely employed,
but may provide complementary information for tumor identification and
characterization. T1 and T2 mapping techniques also offer advantages including
higher resolution, shorter scans, and reduced distortion compared to diffusion
MRI. Quantitative T1 and T2 cut-off values have been proposed to
differentiate prostate cancer in both the transition zone (TZ) and peripheral
zone (PZ), which have regional differences2–4. However, this relies on knowledge of
typical ‘healthy’ values, but patients have been combined over a wide age span
neglecting potential age effects. To date, studies have only explored
age-related alterations in prostate volume and MD5,6. The purpose here is to determine how
T1 and T2 values, as well as MD and volume, change with age in the prostate with
typical aging. Methods
Prostate MRI was acquired on a 3T Siemens Prisma in male
volunteers without diagnosis of prostate cancer (n=74, 19-69 years) using four
scans with the same 40 1.8 mm slices with 1.8x1.8 mm2 in-plane
resolution including: (i) T2-weighted anatomical (TSE, TE 52 ms, 6:44 min) for
volumes, (ii) DWI (SS-EPI, b0, b750 s/mm2, 6 directions, 15
averages, 8:39 min) for MD, (iii) dual flip angle 3D VIBE (flip 1 and 8 deg, TE
2.29 ms, TR 5.11 ms, 4:08 min) for T1 map and (iv) dual-echo TSE (TE 13 and113
ms, 2:17 min) for T2 map. DWI was processed with DIPY, T1 maps were calculated
by Siemens “MapIt”, and T2 maps were computed using in-house software,
incorporating Bloch fitting of proton density weighted (PDW) and T2 weighted
images with B1+ map7. For evaluating MD, T1 and T2 values in
PZ and TZ, separate Regions of Interest (ROIs) were identified manually on the
mean DWI, T1 map and T2 map across multiple slices, within both zones. For
volume measurement, ROIs were drawn on the single-echo T2-weighted anatomical
images for PZ and TZ. Quadratic curve fitting examined the relationship between
T1, T2, MD or volume versus age in both zones. Summary parameters were assessed
for below 45 years (n=32) and above 45 years (n=42) with an unpaired t-test
(p<0.05).Results
High-quality
prostate images and maps are shown for a representative younger (19 years) and
older (69 years) participant demonstrating larger overall volume and elevated T2
and MD in the PZ, but not the TZ in the older person (Figure 1). Table 1
details age group means and standard deviations, with T1, T2, MD in PZ being
significantly higher and more variable in >45-year-olds but not in TZ, and
PZ has higher values than TZ in both age groups. Volume for PZ and TZ were
significantly larger in >45-year-olds. T1, T2, and MD in the PZ exhibited a
positive quadratic association with age being constant over ~19-45 years
followed by increases after ~45 years (Figure 2A,C,E). However,
the older age group is heterogeneous with about half showing elevated values
(T1, T2 or MD) and the other half showing similar values to the younger
individuals. In contrast to PZ, there were no such age relationships in
TZ (Figure 2B,D,F). The volume of PZ, TZ and whole prostate showed a positive
quadratic association with age with a similar inflection point as above.
(Figure 3). The PZ and TZ volumes are 45% and 80%
larger, respectively, at 69 years relative to 19 years.Discussion
Our T1 and T2 values align with previous studies, despite different
acquisition strategies (e.g., MR fingerprinting for T1 and T2, MOLLI for T1,
and multi-echo spin-echo for T2)2–4 and their changes, as well as MD, in the PZ with
typical aging suggest the importance of age considerations in defining prostate
cancer detection thresholds (in addition to the region). Despite a more
pronounced volume change with age in TZ than PZ, no age-related changes were
observed for T1, T2, or MD values in TZ. This suggests that the tissue micro-composition
within the TZ remains consistent throughout the aging process, as opposed to
the PZ that shows marked elevations of all three metrics after the age of 45
years, albeit not in everyone. Quantitative mapping of T1, T2, and MD can
provide insight into prostate changes with typical aging and may be relevant
for understanding prostate cancer risk/evolution in addition to providing an
age-relevant baseline for establishing quantitative
thresholds for the identification of abnormal tissue, including prostate cancer.Acknowledgements
No acknowledgement found.References
- Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey
B, Barentsz J. Prostate Imaging-Reporting and Data System Steering Committee:
PI-RADS v2 Status Update and Future Directions. Eur Urol.
2019;75(3):385-396. doi:10.1016/j.eururo.2018.05.035
- Klingebiel M, Schimmöller L, Weiland E, et al. Value of T2
Mapping MRI for Prostate Cancer Detection and Classification. Journal of
Magnetic Resonance Imaging. 2022;56(2):413-422. doi:10.1002/jmri.28061
- Baur ADJ, Hansen CM, Rogasch J, et al. Evaluation of T1
relaxation time in prostate cancer and benign prostate tissue using a Modified
Look-Locker inversion recovery sequence. Sci Rep. 2020;10(1). doi:10.1038/s41598-020-59942-z
- Yu AC, Badve C, Ponsky LE, et al. Development of a combined
Mr Fingerprinting and Diffusion examination for Prostate cancer. Radiology.
2017;283(3):729-738. doi:10.1148/radiol.2017161599
- Tamada T, Sone T, Toshimitsu S, et al. Age-related and zonal
anatomical changes of apparent diffusion coefficient values in normal human
prostatic tissues. Journal of Magnetic Resonance Imaging.
2008;27(3):552-556. doi:10.1002/jmri.21117
- Turkbey B, Huang R, Vourganti S, et al. Age-related changes
in prostate zonal volumes as measured by high-resolution magnetic resonance
imaging (MRI): A cross-sectional study in over 500 patients. BJU Int.
2012;110(11):1642-1647. doi:10.1111/j.1464-410X.2012.11469.x
- McPhee KC, Wilman AH. Transverse relaxation and flip angle
mapping: Evaluation of simultaneous and independent methods using multiple spin
echoes. Magn Reson Med. 2017;77(5):2057-2065. doi:10.1002/mrm.26285